Business

Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits

CNBC · October 13, 2026 at 2:48 PM

Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.

Read the full article on CNBC ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cnbc.com — the content belongs to CNBC.

Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits

More from CNBC

Meta shares rise for a second straight day as new AI model family impresses

Social Security cost-of-living adjustment for 2027 may be above average. Some say it's not enough

JPMorgan Chase blocks outside AI agents like Muse, Instinct from directly accessing accounts

S&P 500 is little changed as traders mull over bank earnings; chip stocks slide: Live updates

More in Business

Meta shares rise for a second straight day as new AI model family impresses

Social Security cost-of-living adjustment for 2027 may be above average. Some say it's not enough

JPMorgan Chase blocks outside AI agents like Muse, Instinct from directly accessing accounts

S&P 500 is little changed as traders mull over bank earnings; chip stocks slide: Live updates

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Apple’s new home devices are a bet on its upgraded Siri AI